Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 4, 2022
Reporting Period: First Quarter 2022
This filing serves as a notification that the Company issued a press release on May 4, 2022, disclosing its financial results for the first quarter of 2022. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing explicitly states that the detailed results are contained in the attached press release (Exhibit 99.1), which is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only references the issuance of the Q1 2022 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of the Q1 2022 press release but does not include the content of management's commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Unusual Items: None mentioned in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 4, 2022) for actual Q1 2022 financial figures, as they are not present in the 8-K body.
- Verify the Company's status as an emerging growth company (indicated as not applicable in this filing).
- Confirm the trading symbol NEPH on The Nasdaq Stock Market LLC.
- Note that the press release is "furnished" and not "filed," meaning it may not be subject to the same liability standards as the 8-K itself.